TORRANCE, Calif., Jan. 25, 2021 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in the treatment of sickle cell disease, reported today its financial results for the year ended December 31, 2019 and its restated financial results for the year ended December 31, 2018. As previously disclosed in the Current […]
Wednesday, Jan 15, 2025
Breaking News